Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 41.3 0 (0%) Market Cap: 2.02 Bil Enterprise Value: 2.41 Bil PE Ratio: 14.29 PB Ratio: 3.00 GF Score: 77/100

Amphastar Pharmaceuticals Inc at Needham Healthcare Conference Transcript

Apr 15, 2020 / 04:50PM GMT
Release Date Price: $16.19 (-1.40%)
Serge Belanger
Needham & Company, LLC - Analyst

This is Serge Belanger from Needham and Company. Welcome to the 19th annual Needham healthcare conference. Apologies for the delay. We had some technical difficulties. So for the next 30 minutes, we will be talking with the Amphastar Pharmaceuticals team. We have Bill Peters, the Company's CFO. We have Dan Dischner, the VP of corporate communications, as well as Tony Marrs of regulatory affairs.

So gentlemen, welcome, and if you wouldn't mind with starting with a brief corporate update on the Company.

Bill Peters
Amphastar Pharmaceuticals, Inc. - CFO, Treasurer, and SVP, Finance

Yes, thanks, Serge. This is Bill. I am going to turn the call over to Dan for a brief update.

Dan Dischner
Amphastar Pharmaceuticals, Inc. - Director, HR

Okay. Thanks, Bill. I'm going to address the impact -- I think a lot of people are curious on the impact of COVID-19. I will start with addressing that. The Company has several talented, dedicated people who have pulled

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot